Fostemsavir CAS No.:864953-29-7
Min.Order : 1 Pieces Quick Quotation >
Conpany Profile
Product Details
PRODUCT NAME | Fostemsavir | ||
CAS No.: | 864953-29-7 | ||
Synonyms | 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine; | ||
[3-[2-(4-benzoylpiperazin-1-yl)-2-oxoacetyl]-4-methoxy-7-(3-methyl-1,2,4-triazol-1-yl)pyrrolo[2,3-c]pyridin-1-yl]methyl dihydrogen phosphate | |||
UNII-97IQ273H4L; | |||
CS-1059; | |||
Formula: | C25H26N7O8P | Molecular Weight: | 583.49000 |
PSA: | 192.02000 | LogP: | 1.04390 |
Structure:
Description:
Fostemsavir (BMS-663068) is an experimental HIV entry inhibitor and a prodrug of temsavir (BMS-626529). It is under development by Bristol-Myers Squibb for use in the treatment of HIV infection. By blocking the gp120 receptor of the virus, it prevents initial viral attachment to the host CD4+ T cell and entry into the host immune cell; its method of action is a first for HIV drugs. Because it targets a different step of the viral lifecycle, it offers promise for individuals with virus that has become highly resistant to other HIV drugs. Since gp120 is a highly conserved area of the virus, the drug is unlikely to promote resistance to itself via generation of CD4-independent virus.
We can provide this producct with purity 99%.
Recommend Product